既往前肠手术对食管切除术结局的影响:一项匹配回顾性队列研究
该回顾性队列研究纳入2008年至2024年349例食管切除术患者,其中37例有前肠手术史(PFS),按3:1匹配111例无前肠手术史(No-PFS)患者。匹配后PFS组手术时间显著更长(463 vs 426分钟,p=0.038),但中转开腹、早期并发症、再干预或漏率无差异。PFS不影响手术方式或结局,安全性良好,癌症患者生存率有更高趋势(p=0.06)。
要点
- 既往前肠手术不增加食管切除术后并发症、再干预或吻合口漏风险。
- PFS组手术时间显著延长(463 vs 426分钟,p=0.038)。
- PFS组癌症患者生存率有更高趋势(p=0.06),可能与更早诊断和更低临床分期有关。
核心结论
- 既往前肠手术不影响食管切除术的手术方式或结局,安全性良好,不增加并发症风险。
- 因癌症指征行食管切除术的PFS患者因更频繁随访而更早发现、临床分期更低,生存率有更高趋势(p=0.06)。
研究设计与样本
- PFS组37例,按年龄、性别、种族和吸烟状态以3:1最近邻匹配法匹配No-PFS组111例。
主要发现
- PFS组中43%为抗反流手术,35%为贲门失弛缓症Heller肌切开术,14%为减重手术;癌症为食管切除术指征者占59.5%。
- 匹配后PFS组手术时间显著更长(463 vs 426分钟,p=0.038)。
- 中转开腹、早期并发症、再干预或漏率两组无差异(p>0.05)。
- 3例使用间置移植物(结肠、空肠)替代胃作为导管。
- 远期吻合口狭窄无统计学差异,但PFS组无狭窄生存有更低趋势;限于癌症患者的生存分析显示PFS组生存率更高(p=0.06)。
临床怎么用
- 既往前肠手术史不应视为食管切除术的禁忌,但需预期手术时间可能延长。
- 对PFS患者行食管切除术时,可考虑使用间置移植物(结肠、空肠)替代胃作为导管。
- PFS癌症患者因更频繁随访可能更早诊断,应重视随访监测。
局限性
- 回顾性研究设计。
- PFS组样本量较小(N=37)。
- 生存分析仅限癌症患者且差异未达统计学显著性(p=0.06)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Esophagectomy is a challenging procedure indicated for esophageal cancer and complex benign esophageal conditions. The primary aim of this study was to determine the impact of previous foregut surgeries on postoperative outcomes following esophagectomy. METHODS: A retrospective cohort study was performed on patients undergoing esophagectomy between March 1st, 2008, and December 17th, 2024. Two groups were identified, patients with previous foregut surgery (PFS) and patients without previous foregut surgery (No-PFS). PFS (N = 37) was matched in a 3:1 ratio to patients with No-PFS (N = 111) by age, gender, race, and smoking status with "nearest neighbor" method. Demographics and perioperative variables were collected and compared between both groups. Kaplan-Meier method estimated survival and freedom from long-term complications, such as anastomotic stricture and paraconduit hernia. RESULTS: Of 349 patients undergoing esophagectomy, 37 had PFS. These included 43% anti-reflux procedures, 35% Heller myotomy for achalasia, and 14% bariatric surgeries. Diagnosis of cancer was an indication for esophagectomy in 59.5% of cases. After matching, significant difference was found regarding operative time (PFS: 463 vs No-PFS: 426 min; p = 0.038). No difference was observed in conversions to open, early complications, reinterventions or leak rate (p value > 0.05). In 3 cases, an interposition graft (colon, jejunum) was used as conduit instead of stomach. As regards freedom from late anastomotic stricture, although not statistically significant, a trend toward a lower freedom from anastomotic stricture was observed in PFS group. The survival analysis, limited to patients with esophageal cancer, indicated higher survival rates in the PFS group (p = 0.06). CONCLUSIONS: PFS does not impact the approach or outcomes of esophagectomy and is safe with no increased risk of complications. Patients with PFS who had indication of esophagectomy for cancer tended to have better survival rates due to earlier detection and lower clinical stages at diagnosis because of more frequent follow-ups.
引用
- Pontecorvo AA, Cornejo J, Alomari M, et al. Outcomes of esophagectomy in patients with previous foregut surgery: a matched retrospective cohort study. Surg Endosc. 2025. PMID: 40328976. doi:10.1007/s00464-025-11757-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。